Emerson Erik C.

Apimeds Pharmaceuticals US, Inc · Chief Executive Officer

Emerson Erik C. is listed in public filings as director, officer: Chief Executive Officer. This Emerson Erik C. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apimeds Pharmaceuticals US, Inc (APUS). Investors use Emerson Erik C.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apimeds Pharmaceuticals US, IncAPUS$413k215k sharesGrant / ExerciseOct 15, 2025$412.8K215k shares$1.92--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.